Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Novo Nordisk’s chief executive, Mike Doustdar, is a year into [...]
How GLP-1s Feed Our Sick Culture
For women, they’re a depressingly rational choice.
How Has Your Shopping Changed in the Era of Weight-Loss Drugs?
In the last few years, weight-loss drugs like Ozempic have [...]
GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Up
Millions of Americans are experimenting with the drugs. Science can’t [...]
Cuando los medicamentos para perder peso no funcionan
Fármacos como Wegovy y Zepbound han sido aclamados como tratamientos [...]
When Weight-Loss Drugs Don’t Work
Drugs like Wegovy and Zepbound have been hailed as miracle [...]
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
The Trump administration said that had the new prices been [...]
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
By mid-2024, the weight-loss drugs were prescribed for almost 2 [...]
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs
The weight loss medicines are proving to be a test [...]
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the [...]